SB 589 – Oklahoma

Status: Inactive / Dead
Year Introduced: 2021

An Act relating to prescription drugs; defining terms; requiring drug manufacturer to notify Insurance Department of price increases of certain drugs by certain amount and introduction of certain new drugs; establishing timeline for notification; specifying what data notification shall include; applying certain protections to data; requiring pharmacy benefit managers and wholesale drug distributors to report certain data after notification by Department; requiring certain insurers to report spending on certain prescription drugs and drug groups; specifying information required to be reported; requiring insurers to report certain data on drugs and drug groups; requiring certain entities to register with the Department by certain date; requiring certain entities to pay annual assessment to Department; directing assessment to cover certain activities; establishing procedures for determining assessment; specifying procedures for sending requests for payment of assessment; directing monies to certain fund; requiring certain entities certify required reporting; establishing civil penalty for violation of act; authorizing Department to audit reported data; authorizing Department to require certain entities submit corrective action plans; authorizing Department to hold public hearings and subpoena certain entities; requiring Department to prepare and post report on prescription drug prices on website; requiring Department to hold public hearing on report data; specifying required data in report; requiring Department to keep certain information confidential; authorizing Department to promulgate rules; providing for codification; and providing an effective date.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found